Product NDC: | 55111-532 |
Proprietary Name: | Divalproex sodium |
Non Proprietary Name: | Divalproex sodium |
Active Ingredient(s): | 125 mg/1 & nbsp; Divalproex sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55111-532 |
Labeler Name: | Dr. Reddy's Laboratories Ltd |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078979 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090123 |
Package NDC: | 55111-532-78 |
Package Description: | 10 BLISTER PACK in 1 CARTON (55111-532-78) > 10 CAPSULE in 1 BLISTER PACK (55111-532-79) |
NDC Code | 55111-532-78 |
Proprietary Name | Divalproex sodium |
Package Description | 10 BLISTER PACK in 1 CARTON (55111-532-78) > 10 CAPSULE in 1 BLISTER PACK (55111-532-79) |
Product NDC | 55111-532 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Divalproex sodium |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20090123 |
Marketing Category Name | ANDA |
Labeler Name | Dr. Reddy's Laboratories Ltd |
Substance Name | DIVALPROEX SODIUM |
Strength Number | 125 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |